[{"address1": "238 Main Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 327 8775", "website": "https://beamtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 510, "companyOfficers": [{"maxAge": 1, "name": "Mr. John M. Evans M.B.A.", "age": 47, "title": "CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1234010, "exercisedValue": 0, "unexercisedValue": 16127756}, {"maxAge": 1, "name": "Dr. Guiseppe  Ciaramella Ph.D.", "age": 56, "title": "President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1041270, "exercisedValue": 2506545, "unexercisedValue": 5912415}, {"maxAge": 1, "name": "Mr. Sravan Kumar Emany", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 617074, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christine P. Bellon J.D., Ph.D.", "age": 59, "title": "Senior VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 744950, "exercisedValue": 0, "unexercisedValue": 363849}, {"maxAge": 1, "name": "Dr. Amy  Simon M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 779170, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Feng  Zhang Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David R. Liu Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J. Keith Joung M.D., Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Manmohan  Singh Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gopi  Shanker Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 32.05, "open": 31.98, "dayLow": 30.78, "dayHigh": 32.24, "regularMarketPreviousClose": 32.05, "regularMarketOpen": 31.98, "regularMarketDayLow": 30.78, "regularMarketDayHigh": 32.24, "payoutRatio": 0.0, "beta": 2.073, "forwardPE": -6.8118644, "volume": 1611561, "regularMarketVolume": 1611561, "averageVolume": 2104208, "averageVolume10days": 2372220, "averageDailyVolume10Day": 2372220, "bid": 31.07, "ask": 31.34, "bidSize": 5, "askSize": 5, "marketCap": 3168047616, "fiftyTwoWeekLow": 13.525, "fiftyTwoWeekHigh": 36.44, "allTimeHigh": 138.522, "allTimeLow": 13.0, "priceToSalesTrailing12Months": 56.875957, "fiftyDayAverage": 26.0516, "twoHundredDayAverage": 21.44105, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2157647360, "profitMargins": 0.0, "floatShares": 87388756, "sharesOutstanding": 101474944, "sharesShort": 20295552, "sharesShortPriorMonth": 20951122, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.2, "heldPercentInsiders": 0.012610001, "heldPercentInstitutions": 1.02179, "shortRatio": 12.93, "shortPercentOfFloat": 0.22469999, "impliedSharesOutstanding": 101474944, "bookValue": 9.799, "priceToBook": 3.1860394, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -414643008, "trailingEps": -4.41, "forwardEps": -4.58318, "enterpriseToRevenue": 38.736, "enterpriseToEbitda": -4.857, "52WeekChange": 0.30656338, "SandP52WeekChange": 0.14799047, "quoteType": "EQUITY", "currentPrice": 31.22, "targetHighPrice": 80.0, "targetLowPrice": 21.0, "targetMeanPrice": 45.2, "targetMedianPrice": 42.0, "recommendationMean": 1.41176, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 15, "totalCash": 1074969984, "totalCashPerShare": 10.892, "ebitda": -444216000, "totalDebt": 151420000, "quickRatio": 5.888, "currentRatio": 6.017, "totalRevenue": 55701000, "debtToEquity": 15.675, "revenuePerShare": 0.593, "returnOnAssets": -0.23479, "returnOnEquity": -0.4719, "grossProfits": -356086016, "freeCashflow": -166764128, "operatingCashflow": -338177984, "revenueGrowth": -0.32, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -13.076, "financialCurrency": "USD", "symbol": "BEAM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Beam Therapeutics Inc.", "longName": "Beam Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1768610643, "regularMarketTime": 1768597201, "exchange": "NMS", "messageBoardId": "finmb_564610577", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580999400000, "postMarketChangePercent": 1.8827707, "postMarketPrice": 31.8078, "postMarketChange": 0.587801, "regularMarketChange": -0.83, "regularMarketDayRange": "30.78 - 32.24", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2104208, "fiftyTwoWeekLowChange": 17.695, "fiftyTwoWeekLowChangePercent": 1.3083179, "fiftyTwoWeekRange": "13.525 - 36.44", "fiftyTwoWeekHighChange": -5.2199993, "fiftyTwoWeekHighChangePercent": -0.14324917, "fiftyTwoWeekChangePercent": 30.656338, "earningsTimestamp": 1762263000, "earningsTimestampStart": 1762263000, "earningsTimestampEnd": 1762263000, "earningsCallTimestampStart": 1730813400, "earningsCallTimestampEnd": 1730813400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.41, "epsForward": -4.58318, "epsCurrentYear": -4.38955, "priceEpsCurrentYear": -7.1123457, "fiftyDayAverageChange": 5.1684, "fiftyDayAverageChangePercent": 0.19839089, "twoHundredDayAverageChange": 9.77895, "twoHundredDayAverageChangePercent": 0.4560854, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -2.5897, "regularMarketPrice": 31.22, "displayName": "Beam Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]